ClinConnect ClinConnect Logo
Search / Trial NCT05154669

Integrating Financial Coaching and Smoking Cessation Coaching

Launched by NYU LANGONE HEALTH · Nov 30, 2021

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to help people quit smoking. One group of participants will receive standard counseling to help them stop smoking, while the other group will get an integrated approach that combines smoking cessation advice with financial coaching. The goal is to see if adding financial support can make it easier for people to quit smoking.

To be eligible for the study, you must be at least 18 years old, smoke at least five cigarettes a day, and be interested in both smoking and financial counseling. You should also live in New York City, speak either English or Spanish, and have a household income that is below 200% of the federal poverty level. Participants can expect to receive personalized coaching and support to help them quit smoking and improve their financial situation. It's important to note that people with certain medical conditions or those who know someone currently in the study cannot participate. If you're looking for support to quit smoking and fit the eligibility criteria, this trial might be a great opportunity for you!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age ≥18 years,
  • smokes ≥5 cigarettes per day,
  • interested in receiving smoking and financial counseling,
  • self-reported income below 200% of the current federal poverty level,
  • New York City resident,
  • speaks English or Spanish language (the interventions and measures have not been validated in other languages),
  • able to provide informed consent, and
  • does not have a representative who manages his/her funds.
  • Exclusion Criteria
  • people who know a current past study participant (to avoid intervention contamination)
  • * People who have a medical contraindication to using nicotine replacement therapy:
  • allergy to nicotine patch
  • pregnancy or intention to become pregnant over the next 12 months
  • breastfeeding
  • heart attack in the past 2 months
  • underlying arrhythmia
  • ongoing or worsening angina.

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

Patients applied

KS

1 patients applied

Trial Officials

Erin Rogers, DrPH

Principal Investigator

NYU Langone Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials